Makes things clear
BioStonk makes it much easier to understand biotech companies and upcoming clinical trial catalysts. I especially like how it explains trial details, endpoints, and potential risks in plain English. The interface is clean, the information is organized well, and the daily catalyst briefs are useful for quickly seeing what may affect biotech stocks.
Show more